QQ客服 官方微博 反馈留言

	Tubulin colchicine site binding agent LL01 displays potent antitumor efficiency both in vitro and in vivo with suitable drug-like properties
	Wu J.-D.; Cui Y.-J.; Zhou Y.-G.; Tang L.-Q.; Zhang C.-M.; Liu Z.-P.
刊名	Investigational New Drugs
	2019
关键词	Hepatocellular carcinoma Liver microsome stability Multidrug-resistance Pharmacokinetics Tubulin polymerization inhibitor
DOI	10.1007/s10637-019-00753-z
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4562075
专题	山东大学
作者单位	Institute of Medicinal Chemistry, Key Laboratory of Chemical Biology , School of Pharmaceutical Sciences, Shandong U
推荐引用方式 GB/T 7714	Wu J.-D.,Cui Y.-J.,Zhou Y.-G.,et al. Tubulin colchicine site binding agent LL01 displays potent antitumor efficiency both in vitro and in vivo with suitable drug-like properties[J]. Investigational New Drugs,2019.
APA	Wu J.-D.,Cui Y.-J.,Zhou Y.-G.,Tang L.-Q.,Zhang C.-M.,&Liu Z.-P..(2019).Tubulin colchicine site binding agent LL01 displays potent antitumor efficiency both in vitro and in vivo with suitable drug-like properties.Investigational New Drugs.
MLA	Wu J.-D.,et al."Tubulin colchicine site binding agent LL01 displays potent antitumor efficiency both in vitro and in vivo with suitable drug-like properties".Investigational New Drugs (2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。